Prof. Hanns Ulrich Zeilhofer is awarded The PHOENIX Pharmaceutical Sciences Prize 2016

  • D-CHAB
  • IPW
  • Awards

On October 20 2016, the "PHOENIX Pharmaceutical Sciences Prize" was awarded to the group of Prof. Hanns Ulrich Zeilhofer for achievments in the field of Pharmacology and Clinical Pharmaceutics.

by Joachim Schnabl
Prof. Dr. Hanns Ulrich Zeilhofer

The PHOENIX group focuses on pharmaceutical innovation in Germany, Austria and Switzerland since 20 years. PHOENIX awards the best four articles in the categories Pharmacology and Clinical Pharmaceutics, Pharmaceutical Biology, Pharmaceutical Chemistry, and Pharmaceutical Technology.

The D-CHAB cordially congratulates Prof. Dr. Hanns Ulrich Zeilhofer to one of the most significant pharmaceutics awards in the German-speaking countries. The award was given for the work "external pageAnalgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype"
(Nature Communications
2015, 6, 6803).

external pageMore information

JavaScript has been disabled in your browser